Radiology
-
To evaluate whether completeness of reporting of systematic reviews and meta-analyses in major radiology journals has changed since publication of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement; a secondary objective is to evaluate whether completeness of reporting (ie, PRISMA) is associated with study quality (ie, Assessing the Methodological Quality of Systematic Reviews [AMSTAR]). ⋯ http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.13130273/-/DC1.
-
To compare serum creatinine (SCr) level- and estimated glomerular filtration rate (eGFR)-based screening methods for identifying adult inpatients at risk for contrast medium-induced nephrotoxicity (CIN). ⋯ Screening using eGFR <45 mL/min/1.73 m(2) instead of common SCr thresholds would significantly increase the number of inpatients identified to be at risk for CIN but would reduce misidentification of a large number of inpatients at low risk according to eGFR criteria.
-
Review
Imaging review of the temporal bone: part I. Anatomy and inflammatory and neoplastic processes.
From a clinical-radiologic standpoint, there are a limited number of structures and disease entities in the temporal bone with which one must be familiar in order to proficiently interpret a computed tomographic or magnetic resonance imaging study of the temporal bone. It is helpful to examine the region in an organized and systematic fashion, going through the same checklist of key structures each time. This is the first of a two-part review that provides a practical approach to understanding temporal bone anatomy, localizing a pathologic process with a focus on inflammatory and neoplastic processes, identifying pertinent positives and negatives, and formulating a differential diagnosis.
-
To assess quantitative susceptibility mapping (QSM) in the depiction of the subthalamic nucleus (STN) by using 3-T magnetic resonance (MR) imaging. ⋯ QSM at 3-T MR imaging performs significantly better than current standard-of-care sequences in the depiction of the STN.
-
Controlled Clinical Trial
Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity.
To assess tumor conspicuity and radiation dose with a new multidetector computed tomography (CT) protocol for pancreatic imaging that combines spectral CT and split-bolus injection. ⋯ Split-bolus spectral multidetector CT resulted in vascular, liver, and pancreatic attenuation and tumor conspicuity equal to or greater than that with multiphase CT, with a 43% reduction in radiation dose.